BEIJING (Xinhua): Rolf Hilgenfeld, a German coronavirus research expert and professor at Lubeck University, brought two inhibitors developed for Sars-CoV to China to test their effects on the 2019 novel coronavirus (2019-nCoV), according to China Media Group (CMG).
Hilgenfeld and his team have been devoted to the research of Sars-CoV inhibitors for many years. The inhibitor uses protease acting on the virus to prevent the protein from cracking, thus preventing the formation of the mature virus.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
